Marine Gilabert

3.7k total citations · 1 hit paper
73 papers, 1.8k citations indexed

About

Marine Gilabert is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Marine Gilabert has authored 73 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 19 papers in Epidemiology. Recurrent topics in Marine Gilabert's work include Pancreatic and Hepatic Oncology Research (28 papers), Neuroendocrine Tumor Research Advances (16 papers) and Hepatocellular Carcinoma Treatment and Prognosis (14 papers). Marine Gilabert is often cited by papers focused on Pancreatic and Hepatic Oncology Research (28 papers), Neuroendocrine Tumor Research Advances (16 papers) and Hepatocellular Carcinoma Treatment and Prognosis (14 papers). Marine Gilabert collaborates with scholars based in France, Canada and United States. Marine Gilabert's co-authors include Jean‐Luc Raoul, Jordi Bruix, Alejandro Forner, Olivıer Turrini, Gilles Piana, Julien Edeline, Jean‐Robert Delpéro, François Bertucci, Anthony Gonçalvès and Patrice Viens and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Marine Gilabert

70 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of intermediate-stage hepatocellular carcinoma

2014 357 citations Marine Gilabert, Jean‐Luc Raoul et al. profile →

Peers

Marine Gilabert

ONCOL

HEPAT

PRM

Yiyi Yu China

Zhi-Quan Wu China

Felix Chu United States

Gina M. Vaccaro United States

Lehua Shi China

Paxton V. Dickson United States

Nobuyuki Mizunuma Japan

Francesco Sclafani United Kingdom

Yihebali Chi China

He Huang China

Yiyi Yu China

Marine Gilabert

741 ×0.8

ONCOL

253 ×0.5

HEPAT

460 ×1.1

PRM

327 ×0.8

447 ×1.1

Citations per year, relative to Marine Gilabert Marine Gilabert (= 1×) peers Yiyi Yu

Countries citing papers authored by Marine Gilabert

Since Specialization

Citations

This map shows the geographic impact of Marine Gilabert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marine Gilabert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marine Gilabert more than expected).

Fields of papers citing papers by Marine Gilabert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marine Gilabert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marine Gilabert. The network helps show where Marine Gilabert may publish in the future.

Co-authorship network of co-authors of Marine Gilabert

This figure shows the co-authorship network connecting the top 25 collaborators of Marine Gilabert. A scholar is included among the top collaborators of Marine Gilabert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marine Gilabert. Marine Gilabert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gilabert, Marine, Philippe Rochigneux, Olivıer Turrini, et al.. (2024). Management and outcomes of brain metastases from pancreatic adenocarcinoma: a pooled analysis and literature review. Frontiers in Oncology. 13. 1326676–1326676. 1 indexed citations

Hautefeuille, Vincent, Édouard Auclin, Astrid Lièvre, et al.. (2022). Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study. British Journal of Cancer. 126(10). 1394–1400. 5 indexed citations

Garnier, Jonathan, Jacques Ewald, Ugo Marchèse, et al.. (2020). Borderline or locally advanced pancreatic adenocarcinoma: A single center experience on the FOLFIRINOX induction regimen. European Journal of Surgical Oncology. 46(8). 1510–1515. 11 indexed citations

Samalin, Emmanuelle, Anthony Turpin, Faïza Khemissa, et al.. (2019). Regorafenib combined with irinotecan as second-line treatment in patients with metastatic gastro-oesophageal adenocarcinomas: A randomized phase 2 trial (PRODIGE 58 – UCGI 35 – REGIRI). Annals of Oncology. 30. iv21–iv21. 2 indexed citations

Lopresti, Alexia, Fabrice Malergue, François Bertucci, et al.. (2019). Sensitive and easy screening for circulating tumor cells by flow cytometry. JCI Insight. 4(14). 37 indexed citations

Rochigneux, Philippe, et al.. (2018). Hyperprogressive Disease in Anorectal Melanoma Treated by PD-1 Inhibitors. Frontiers in Immunology. 9. 797–797. 34 indexed citations

Turrini, Olivıer, Marine Gilabert, Jacques Ewald, et al.. (2017). Resectable pancreatic head adenocarcinoma: Is R0 resection an illusion? Genetic evaluation of venous resection margin affirmed unrecognized disease. Journal of Visceral Surgery. 154(5). 329–333. 3 indexed citations

Rho, Young Soo, Marine Gilabert, Karol Połom, et al.. (2017). Comparing Clinical Characteristics and Outcomes of Young-onset and Late-onset Colorectal Cancer: An International Collaborative Study. Clinical Colorectal Cancer. 16(4). 334–342. 54 indexed citations

Chanez, Brice, François Bertucci, Marine Gilabert, et al.. (2017). A scoring system to guide the decision for a new systemic treatment after at least two lines of palliative chemotherapy for metastatic cancers: a prospective study. Supportive Care in Cancer. 25(9). 2715–2722. 3 indexed citations

10.

Raoul, Jean‐Luc, Xavier Adhoute, Marine Gilabert, & Julien Edeline. (2016). How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinoma. World Journal of Hepatology. 8(35). 1541–1541. 10 indexed citations

11.

Gilabert, Marine, Young Soo Rho, & Petr Kavan. (2016). Targeted Therapies Provide Treatment Options for Poorly Differentiated Pancreatic Neuroendocrine Carcinomas. Oncology. 92(3). 170–172. 10 indexed citations

12.

Rho, Young Soo, Aline Mamo, Marine Gilabert, et al.. (2015). Clinical Practice Patterns in Chemotherapeutic Treatment Regimens for Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 15(2). 135–140. 27 indexed citations

13.

Gilabert, Marine, Ézéquiel Calvo, Tewfik Hamidi, et al.. (2014). Pancreatic Cancer‐Induced Cachexia Is Jak2‐Dependent in Mice. Journal of Cellular Physiology. 229(10). 1437–1443. 54 indexed citations

14.

Gilabert, Marine, Christophe Ginestier, François Bertucci, et al.. (2014). Poly(ADP-Ribose) Polymerase 1 (PARP1) Overexpression in Human Breast Cancer Stem Cells and Resistance to Olaparib. PLoS ONE. 9(8). e104302–e104302. 55 indexed citations

15.

Gilabert, Marine, María I. Vaccaro, Martín E. Fernández-Zapico, et al.. (2013). Novel role of VMP1 as modifier of the pancreatic tumor cell response to chemotherapeutic drugs. Journal of Cellular Physiology. 228(9). 1834–1843. 11 indexed citations

16.

Gonçalvès, Anthony, Renaud Sabatier, Emmanuelle Charafe‐Jauffret, et al.. (2013). Cancer du sein triple-négatif : caractéristiques histocliniques et moléculaires, prise en charge et perspectives thérapeutiques. Bulletin du Cancer. 100(5). 453–464. 16 indexed citations

17.

Gilabert, Marine, François Bertucci, Benjamin Esterni, et al.. (2011). Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: response, survival and prognostic factors.. PubMed. 31(3). 1079–86. 15 indexed citations

18.

Gonçalvès, Anthony, Pascal Finetti, Renaud Sabatier, et al.. (2010). Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis. Breast Cancer Research and Treatment. 127(1). 273–281. 60 indexed citations

19.

Gonçalvès, Anthony, Benjamin Esterni, Carole Tarpin, et al.. (2009). Docetaxel first-line therapy in HER2-negative advanced breast cancer: a cohort study in patients with prospectively determined HER2 status. Anti-Cancer Drugs. 20(10). 946–952. 6 indexed citations

20.

Jiménez, Sònia, Ángeles García‐Criado, Dolors Tàssies, et al.. (2005). Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Lara D. Veeken. 44(6). 756–761. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact